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Abstract The transport of activated fatty acids across the
mitochondrial outer membrane has not been fully addressed. A
polyanion (Mn = 22 kDa) inhibited the ADP-stimulated carni-
tine-dependent oxidation of both palmitoyl-CoA and palmitate
plus CoA as well as mitochondrial hexokinase binding. In
contrast, the oxidation of palmitoylcarnitine plus malate, as well
as glutamate oxidation, was essentially unaffected. Mitochon-
drial carnitine palmitoyltransferase-1 was not inhibited by the
polyanion. The data suggest an additional component in
carnitine-dependent mitochondrial fatty acid oxidation, possibly
porin.
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1. Introduction
Recent evidence has shown that the mitochondrial outer
membrane plays an important role in regulating metabolite
£ux, much of which is controlled by a voltage-dependent
anion channel (VDAC), also known as mitochondrial porin
[1^6]. Each mitochondrial outer membrane channel is thought
to be formed by a monomeric VDAC polypeptide with a
molecular weight in the range of 30 kDa. In the open state,
the pore radius of VDAC is estimated to be 1.2^1.5 nm, large
enough to allow for passage of the non-electrolytes polyethy-
lene glycol (Mav = 3.4 kDa), inulin (Mav = 5.0 kDa) and dex-
tran (Mav = 6.0 kDa). In the closed state, it is impermeable to
inulin and PEG-3.4 kDa and the estimated pore size is 0.85
nm.
Regulation of porin in its isolated form in planar phospho-
lipid bilayer or liposome reconstitution experiments and in its
native environment using patch-clamp techniques has been
demonstrated [7^17]. Collectively, the data suggest that porin
plays a role in metabolite £ux by modulation of its gating
properties. Additionally, a protein modulating the open/closed
state of the pore has been identi¢ed, partially puri¢ed and
characterized from several sources [12,17]. This protein mod-
ulator was shown to control respiration, most likely by limit-
ing the ADP and substrate supply through VDAC, thereby
providing a means for regulating the mitochondrial function.
Porin has also been shown to interact with other proteins
present in contact sites, for example hexokinase [18^21].
This speci¢c binding of hexokinase to VDAC at contact sites
allows for preferential access to mitochondrial-produced ATP
and may also contribute to the regulation of mitochondrial
energy metabolism.
A number of studies on the function of VDAC in regulating
the metabolite £ux have involved the use of large polyvalent
anions [13,16]. One, a synthetic polyanion prepared by Ko«nig
et al. (a copolymer of methacrylate, maleate and styrene in a
1:2:3 proportion), strongly inhibited inner membrane trans-
porters and ATP/ADP uptake in intact mitochondria [22^27].
The polyanion at nM concentrations was shown to induce a
closed state of the mitochondrial outer membrane channel.
Since the polyanion is too large to enter through the pore,
polyanion-induced closure of VDAC is thought to be respon-
sible for the observed inhibition of the inner membrane trans-
porters and ATP/ADP uptake.
While the transport of negatively charged metabolites
across the mitochondrial outer membrane through VDAC
has been well characterized, the transport of activated fatty
acids has not been addressed. We proposed that the transport
of the negatively charged CoA derivatives of fatty acids
through the mitochondrial outer membrane also involves
VDAC. Closure of the outer membrane VDAC would not
only limit ADP and ATP transport, but would also limit
the transport of fatty acyl-CoAs into the mitochondria. In
order to test this hypothesis, a polyanion similar to Ko«nig’s
was prepared and used in experiments with isolated rat liver
mitochondria.
2. Materials and methods
2.1. Synthesis of polyanion
All reagents for the synthesis of polyanion were obtained from
Aldrich Chemical Company and used as received, except where noted.
Methacrylic acid was distilled under reduced pressure. Styrene was
washed with 10% NaOH, ¢ve times with distilled water, dried with
MgSO4, ¢ltered and passed through a bed of neutral alumina. Tol-
uene was washed with concentrated H2SO4, ¢ve times with distilled
water, dried with MgSO4 and ¢ltered. All solutions were purged with
argon prior to use. The molecular weight was determined on a Perkin-
Elmer Series 10-LC GPC/HPLC instrument using tetrahydrofuran
(THF) as solvent and polystyrene standards for calibration. 1H-
NMR (200 MHz) measurements were obtained on a Varian Gemini
200 NMR spectrometer using acetone-d6 as solvent and tetramethyl-
silane as reference.
Polyanion was prepared following the procedure outlined by Ko«nig
et al. [22] with slight modi¢cations. The initiator used for polymer-
ization was 2,2-azobisisobutyronitrile (AIBN) and the reaction time
was reduced to 10 min. An average molecular weight (Mn) of 22 kDa
and polydispersity index (Mw/Mn) of 2.3 versus polystyrene standards
was obtained by size exclusion chromatography. The copolymer com-
position determined by 1H-NMR (acetone-d6) was 48% styrene,
37.5% maleate and 14.5% methacrylate (3.3:2.6:1); N (ppm) 0.9 (m,
methacrylate -CH3), 2.3 (m, methacrylate -C-CH2- and styrene -CH-
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CH2-), 2.5 (m, styrene -CH-CH2-), 3.3 (m, maleate -CH-CH-), 7.25
(m, styrene aromatic H).
While we were initially unable to obtain the original 10 kDa poly-
anion from Dr T. Ko«nig, at the completion of this study, we received
a small sample of Ko«nig’s polyanion from Dr M. Colombini.
2.2. Isolation of rat liver mitochondria
Mitochondria were isolated from livers of male Sprague-Dawley
rats (390^760 g) in 220 mM mannitol, 70 mM sucrose, 5 mM
MOPS, pH 7.4 (MSM), by di¡erential centrifugation according to
Hoppel et al. [28]. Mitochondria used for hexokinase binding experi-
ments were further puri¢ed using a self forming Percoll gradient [28].
2.3. Assays
Oxygen uptake was monitored at 30‡C using a Clark oxygen elec-
trode as described by Tomec and Hoppel [29]. The incubation me-
dium contained 100 mM KCl, 50 mM MOPS, 5 mM KPi, 1.0 mM
EGTA, 1.0 mg defatted bovine serum albumin (BSA)/ml, pH 7.0, and
1.0 mg of mitochondrial protein in a ¢nal volume of 0.5 ml. Respi-
ration was determined in the absence and presence of polyanion, 0^
9.1 nmol polyanion per mg mitochondrial protein, by the addition of
substrate to the incubation medium following depletion of endoge-
nous substrates by small amounts of ADP. Experiments with mito-
chondria subjected to digitonin treatment or hypotonic treatment to
disrupt the outer membrane were performed as described by Bodrova
et al. [30]. Incubation medium contained 250 mM sucrose (45 mM
sucrose for hypotonic conditions), 1 mM EGTA, 5 mM MOPS, 5 mM
KPi, pH 7.4, and 1.0 mg rat liver mitochondria. Since these experi-
ments were done with palmitoyl-CoA as the substrate, 1 mg defatted
BSA/ml was added to the incubation media. Disruption of outer
membrane with 0.1 mM digitonin was done in the 250 mM sucrose
medium. The digitonin concentration for outer membrane disruption
was determined by titration experiments and found to be similar to
that used by Bodrova et al. [30]. Integrity of the mitochondrial outer
membrane was assessed as described by Xu et al. [31].
Hexokinase was isolated as described by Wilson et al. [32]. For
determination of hexokinase binding, rat liver mitochondria (2.5 mg)
were incubated on ice for 30 min in a ¢nal volume of 250 Wl in MSM,
with the following additions: (1) no added polyanion or hexokinase,
(2) 11.3 nmol polyanion, (3) 500 mU hexokinase, (4) 11.3 nmol poly-
anion and 500 mU hexokinase. After 30 min incubation at 0‡C, the
samples were layered on 1 ml MSM and the mitochondria recovered
by centrifugation (Beckman microcentrifuge, 12 000Ug, 5 min, 4‡C).
The pellets were resuspended in 250 Wl MSM, 1% cholate and 50 Wl
aliquots (0.5 mg) were assayed for hexokinase activity [33]. Aliquots
of samples 1 and 2 were also assayed following the addition of 10 mU
hexokinase per mg mitochondrial protein.
Carnitine palmitoyltransferase I (CPT-I) activity was measured us-
ing the radiochemical forward assay exactly as referenced [28]. CPT-I
activity is de¢ned as the malonyl-CoA/etomoxiryl-CoA suppressible
activity. Etomoxiryl-CoA was synthesized as described by Hoppel et
al. [28]. Both hexokinase and CPT-I activities are expressed as nmol/
min or mU/mg mitochondrial protein.
Protein was determined with the biuret assay using BSA as a stand-
ard [34].
3. Results
3.1. Characterization of polyanion
Polymerization, carried out in the presence of AIBN as the
initiator, led to a polyanion with a slightly di¡erent composi-
tion than the 1:2:3 methacrylate:maleate:styrene obtained by
Ko«nig et al. The maleate content, based on 1H-NMR data, is
37.5%, which is slightly higher than that obtained by Ko«nig.
The styrene content is 48% and the methacrylate content is
14.5%. The styrene and methacrylate content is slightly lower
than that found in Ko«nig’s polyanion. Size exclusion chroma-
tography of the polyanion versus polystyrene standards
yielded a molecular weight (Mn) of 22 kDa and polydispersity
(Mw/Mn) of 2.3, compared to a molecular weight of 10 kDa
obtained by Ko«nig. The results show that the polyanion syn-
thesized by us has a high molecular weight, making it too
large to pass through the mitochondrial outer membrane
pores, and a fairly narrow molecular weight distribution, in-
dicating little or no contamination by low molecular weight
polymerization products. To avoid confusion with Ko«nig’s
polyanion, we will label this polyanion as 22 kDa polyanion
(PA-22).
3.2. E¡ect of polyanion (22 kDa) on mitochondrial respiration
We proposed that the polyanion would not only a¡ect ad-
enine nucleotide movement through porin, but also that of
palmitoyl-CoA. The in£uence of polyanion (PA-22) on gluta-
mate oxidation was examined (Fig. 1). The state 3 (ADP-
available) rate was not a¡ected. Additionally, no e¡ect was
observed on the state 4 (ADP-limiting) rate, respiratory con-
trol ratio and ADP/O ratios or when either high ADP or
uncoupler (DNP) were used. These data contrast with the
observation of Ko«nig et al. of a strong, time-dependent inhib-
ition of the above respiratory parameters with glutamate plus
malate as a substrate [22]. Pyruvate and octanoate oxidation
(data not shown) also are not a¡ected.
Next, we tested the e¡ect of PA-22 on fatty acid oxidation
in isolated rat liver mitochondria. As shown in Fig. 2, the
oxidation of palmitoylcarnitine in the presence of malate
was little a¡ected by PA-22. The state 3, high ADP and un-
coupled respiratory rates were slightly decreased at the
amount of PA-22 used (4.5 nmol/mg mitochondrial protein).
In contrast, the carnitine-dependent oxidation of palmitoyl-
CoA in the presence of malate is inhibited by PA-22. At
4.5 nmol PA-22/mg mitochondrial protein, the state 3 rate
Fig. 1. Representative oxidative phosphorylation traces with gluta-
mate as substrate in the absence and presence of polyanion. Addi-
tions of substrates were made following initial addition of 1 mg rat
liver mitochondria (RLM) and 4.5 nmol polyanion (PA; when indi-
cated) to 0.5 ml oxygen electrode mixture. The numbers on the trac-
ings represent the rate of oxygen consumption in nanoatoms oxy-
gen/min/mg mitochondrial protein.
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of palmitoyl-CoA oxidation is decreased by 70% and maximal
(2 mM ADP) stimulated rates are inhibited by 58% as shown
in Fig. 2. There was no reversal of the oxidation following
addition of uncoupler, further indicating a lack of the PA-22
on ADP uptake. The residual oxidation rate is similar to the
rate of state 4 oxidation, suggesting complete inhibition of
substrate oxidation.
Further experiments were done to test the concentration-
dependence of polyanion inhibition on fatty acid substrates.
The maximal ADP-stimulated carnitine-dependent oxidation
of palmitoyl-CoA (Fig. 3) shows a concentration-dependent
inhibition by PA-22, with near maximum inhibition at
2.5 nmol polyanion per mg mitochondria (60.8% inhibition).
Higher concentrations of polyanion did not signi¢cantly in-
crease inhibition, 66.6 þ 9.6% (n = 4) at 9.1 nmol polyanion
per mg mitochondria. The carnitine-dependent oxidation of
palmitate plus CoA in the presence of malate was likewise
inhibited, with maximum inhibition already apparent at
2.3 nmol polyanion (61.3 þ 2.0%, n = 3). Since state 4 rates
are not a¡ected, the PA-22 inhibition of state 3 respiration
appears to be complete. The concentration of PA-22 required
for 50% inhibition was 1.0 WM for both substrates. Inhibition
of palmitoylcarnitine is observed only at high concentrations
of polyanion, while the oxidation of glutamate was not af-
fected at all. At concentrations of 0.5 nmol polyanion per mg
mitochondria (half-maximal inhibition at 1.0 WM), the molar
ratio of polyanion to mitochondrial porin is approximately
3.5 (based on porin comprising approximately 0.5% of total
mitochondrial protein). Outer membrane disruption by digi-
tonin treatment led to the same pattern of inhibition of pal-
mitoyl-CoA oxidation rates as in non-treated mitochondria
(Fig. 4). Furthermore, under hypotonic conditions (45 mM
sucrose), PA-22 is still a potent inhibitor of palmitoyl-CoA
oxidation. The selective inhibition of carnitine-dependent
oxidation of palmitoyl-CoA by PA-22 is not restricted to rat
liver mitochondria. Comparable results were obtained with rat
heart and rat skeletal mitochondria (data not shown).
Fig. 2. Representative oxidative phosphorylation traces with palmitoylcarnitine and palmitoyl-CoA as substrates in the absence and presence of
polyanion. Additions of 35 nmol ADP, 2.5 Wmol malate were made following an initial addition of 1 mg rat liver mitochondria (RLM) and
4.5 nmol polyanion (PA; when indicated) to 0.5 ml oxygen electrode mixture. Subsequent additions are indicated on traces. pal-carn = 20 nmol
palmitoylcarnitine, l-carn = 2.5 Wmol l-carnitine, pal-CoA = 20 nmol palmitoyl-CoA. The numbers on the tracings represent the rate of oxygen
consumption in nanoatoms oxygen/min/mg mitochondrial protein.
Fig. 3. E¡ect of polyanion on maximal ADP-stimulated oxidative
phosphorylation. Rates (nanoatoms oxygen/min/mg) obtained at
0 nmol polyanion were set to 100% for each experiment: glutamate
(F) = 86.6 þ 22.8 (n = 6), palmitoyl-CoA (b) = 88.9 þ 20.8 (n = 6), pal-
mitoylcarnitine (8) = 107.0 þ 32.1 (n = 4), palmitate (R) = 69.2 þ 18.0
(n = 3).
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3.3. E¡ect of polyanion on hexokinase binding to rat liver
mitochondria
The polyanion prepared by Ko«nig et al. has been reported
to bind to porin (also known as hexokinase binding protein)
with concomitant changes in the open/closed state of this out-
er membrane pore protein. Does PA-22 interact with porin?
To address this question, we utilized the speci¢c binding of
hexokinase to porin and tested the binding of hexokinase to
isolated rat liver mitochondria in the presence and absence of
polyanion. Hexokinase binding in rat liver mitochondria (37.8
mU hexokinase/mg mitochondria) was reduced over 80% in
the presence of 4.5 nmol polyanion per mg mitochondrial
protein (6.5 mU hexokinase/mg mitochondria). When equal
amounts of hexokinase were added to the assay mixtures con-
taining either untreated mitochondria or mitochondria that
were exposed to PA-22, complete recovery of hexokinase ac-
tivity was observed. Thus, there was no e¡ect of residual or
bound polyanion on the measurement of hexokinase activity.
These data suggest that PA-22 interacts with porin.
3.4. E¡ect of polyanion on CPT-I activity
Since the polyanion inhibited the carnitine-dependent oxi-
dation of palmitate and palmitoyl-CoA, which is reliant on
CPT-I, but not the oxidation of palmitoylcarnitine, we asked
whether PA-22 inhibits the formation of palmitoylcarnitine.
To this end, we determined the maximally expressed activity
of CPT-I in isolated rat liver mitochondria and used both
malonyl-CoA as well as etomoxiryl-CoA as speci¢c inhibitors
to delineate CPT-I (Table 1). As evident from the near com-
plete inhibition by malonyl-CoA and etomoxiryl-CoA, at both
50 and 160 WM palmitoyl-CoA concentrations, all overt ac-
tivity measured is CPT-I in these mitochondria. Under these
conditions, PA-22 did not inhibit CPT-I activity.
4. Discussion
We have synthesized a polyanion with a molecular weight
of 22 kDa which selectively inhibits the carnitine-dependent
oxidation of palmitate and palmitoyl-CoA. The overall rate of
oxygen consumption is inhibited by approximately 60%. How-
ever, as state 4 rates are not a¡ected, the percentage inhibition
of substrate-supported state 3 rates by PA-22 is nearly com-
plete. Since the oxidation of palmitoylcarnitine is not inhib-
ited at PA-22 concentrations where the carnitine-dependent
oxidation of palmitate and palmitoyl-CoA is already maxi-
mally inhibited, the site of inhibition must be between palmi-
toyl-CoA and palmitoylcarnitine. A potential step could be
CPT-I, which catalyzes the formation of palmitoylcarnitine
from palmitoyl-CoA and carnitine. Direct measurement of
maximally expressed CPT-I activity under conditions where
virtually all activity was suppressed by malonyl-CoA, as
well as etomoxiryl-CoA, revealed no inhibition by PA-22.
These data rule out a direct interaction between CPT-I and
PA-22 and eliminate CPT-I as the site of inhibition of fatty
acid oxidation by PA-22. Thus, a step a¡ecting palmitoyl-
CoA but not the formation or the handling of palmitoylcar-
nitine is implicated.
Since porin is known to be responsible for metabolite £ux
across the mitochondrial outer membrane, we raised the ques-
tion whether PA-22 limits the availability of palmitoyl-CoA to
the catalytic site of CPT-I by interacting with the outer mem-
brane pore channel protein porin? Similar to Ko«nig’s polyan-
ion, which has been shown to limit substrate supply through
porin, the PA-22 was shown to interact with porin, however,
the metabolic consequences of the binding of these two poly-
anions are di¡erent. While Ko«nig’s polyanion inhibited state 3
respiration with glutamate/malate and succinate (and in pre-
liminary experiments in our laboratory, it also inhibited the
carnitine-dependent oxidation of palmitoyl-CoA), the PA-22
selectively inhibited the carnitine-dependent oxidation of pal-
mitoyl-CoA and palmitate plus CoA, but had no e¡ect on the
other substrates we tested (glutamate, palmitoylcarnitine, pyr-
uvate, octanoate). Furthermore, while inhibition of glutamate
oxidation by Ko«nig’s polyanion was reversible by high ADP
and uncoupler, the inhibition of the carnitine-dependent oxi-
dation of palmitoyl-CoA by both polyanions was not re-
versed. Thus, the inhibition of carnitine-dependent fatty acid
oxidation by PA-22 must be through a mechanism other than
the inhibition of adenine nucleotide transport through the
mitochondrial outer membrane.
In experiments involving the carnitine-dependent palmitoyl-
CoA oxidation in mitochondria that had the outer membrane
damaged by either digitonin treatment, hypotonic swelling
failed to reverse inhibition by PA-22. In preliminary experi-
ments with French press mitoplasts, in which 81^85% of the
outer membrane marker activity was removed, 50% of CPT-I
and long-chain acyl-CoA synthetase (LCAS) activity re-
mained and there was no loss of carnitine-dependent palmi-
toyl-CoA oxidation [28], inhibition by PA-22 was still ob-
served. The CPT-I and LCAS activities remaining with these
Table 1
E¡ect of polyanion on CPT-I activity
Incubation conditions [Palmitoyl-CoA]
50 WM 160 WM
No addition 17.9 29.6
Etomoxiryl-CoAa 0.4 1.2
200 WM Malonyl-CoA 1.1 3.7
Polyanion (4.5 nmol/mg mitochondrial
protein)
17.8 34.6
aMitochondria were pre-incubated with 0.5 WM etomoxiryl-CoA as
described in [28].
Fig. 4. E¡ect of polyanion on maximal ADP-stimulated oxidative
phosphorylation of palmitoyl-CoA in intact and disrupted rat liver
mitochondria. Rates (nanoatoms oxygen/min/mg) obtained at 0 nmol
polyanion were set to 100% for each experiment: 250 mM sucrose
(8) = 57.4, 250 mM sucrose, 0.1 mM digitonin (R) = 47.3, 45 mM
sucrose (b) = 48.8.
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French press-generated mitoplasts are localized in contact
sites [28]. These mitochondrial structures are also present in
mitochondria subjected to digitonin treatment [18] or hypo-
tonic swelling [19] and it are these contact sites that represent
the purported site of action for PA-22.
Since the size of the polyanion is too large to cross the
mitochondrial outer membrane, its inhibitory e¡ect on palmi-
tate/palmitoyl-CoA oxidation must be exerted at the cytosolic
side of the outer membrane. With the catalytic site facing the
intermembrane space and the regulatory or malonyl-CoA
binding site facing the cytosol [35], the inhibition of palmito-
yl-CoA oxidation by the polyanion could be envisaged as
preventing the movement of palmitoyl-CoA through porin
from the cytosol to the catalytic site of CPT-I on the inner
surface of the mitochondrial outer membrane. The fact that
the polyanion strongly inhibited the speci¢c binding of hexo-
kinase to porin in isolated rat liver mitochondria, combined
with a lack of CPT-I inhibition, lends support to this possi-
bility. Recently, both the catalytic and malonyl-CoA binding
site of CPT-I were reported to be localized to the cytosolic
side of the mitochondrial outer membrane [36]. Again, the
lack of inhibition of maximally expressed CPT-I activity sug-
gests a mode of interaction of PA-22 on palmitoyl-CoA oxi-
dation that does not involve CPT-I.
In conclusion, the PA-22 selectively inhibits the carnitine-
dependent oxidation of palmitoyl-CoA. The data suggest that
this inhibition is accomplished by preventing the provision of
palmitoyl-CoA to CPT-I. The peripheral benzodiazepine re-
ceptor, which consists of porin (outer membrane), adenine
nucleotide translocase (inner membrane) and an 18 kDa outer
membrane protein, is involved in cholesterol transport
through the mitochondrial outer membrane. Binding of the
diazepine binding inhibitor (DBI; 10 kDa) greatly facilitates
the transport of cholesterol through the mitochondrial outer
membrane to the cytochrome P450 side chain cleavage en-
zyme localized on the outer surface of the adrenal mitochon-
drial inner membrane [37,38]. By analogy, we speculate that a
similar mechanism exists for the movement of long-chain acyl-
CoAs through the mitochondrial outer membrane. The near
complete homology between the DBI and the acyl-CoA bind-
ing protein (ACBP) certainly enhances this possibility. Bind-
ing of the polyanion to porin could a¡ect the transport of
long-chain acyl-CoAs either indirectly by preventing the inter-
action of ACBP with porin or directly by a¡ecting pore clo-
sure. Further studies concerning the transport of long-chain
acyl-CoAs through the mitochondrial outer membrane are
warranted.
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